Skip to main content
OpenTrials
Completed

NCT Number: NCT02430324

The Multicenter Italian INCEPT (INfarto CErebrale Post-Traumatico) Study

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide (Ghajar, 2000). With an estimated annual incidence of up to 500 per 100,000 population and more than 200 hospital admissions per 100,000 admissions in Europe each year, TBI is a major challenge to public health (Lingsma, 2010). Mortality and morbidity after TBI depend on several factors, either associated with patients characteristics, the cause of TBI, the neurological and general severity and secondary brain insults, the structural brain alterations as diagnosed at brain computed tomography (CT) (Rosenfeld, 2012).

The prognostic value of brain CT characteristics is well documented, including the status of basal cisterns, midline shift, the presence and type of intracranial lesions, and traumatic subarachnoid hemorrhage (Maas, 2008). Postraumatic cerebral ischemia, which includes functionally impaired yet still viable tissue, so-called ischemic penumbra, and irreversible cerebral infarction (PTCI), is frequent in patients who die after moderate or severe head trauma (Stocchetti, 2014).

Evidence of antemortem occurrence of PTCI is limited to three single-center retrospective studies, reporting a varying prevalence of 1.9%, 8% and 19.1% (Mirvis, 1990; Marino, 2006; Tawil, 2008). Increased intracranial pressure (ICP), blunt cerebral vascular injury, need for craniotomy and treatment with recombinant activated factor VII, have been demonstrated to be risk factors for PTCI. In one study, PTCI was an independent risk factor for poor outcome after moderate or severe head trauma with a two-fold increase in mortality and severe disability (Marino, 2006).

PTCI can be an important diagnosis in patients with significant TBI for various reasons. First, it might influence long-term outcome. Second, as an outcome that is measurable, and relevant to survival and lifestyle, PTCI could be used as an outcome measure in randomized controlled trials. Third, diagnosis of PTCI could be used as a standard diagnostic reference to validate early surrogate indicators of cerebral ischemia.

The investigators therefore planned a multi-center prospective study to investigate the impact of PTCI on disability at hospital discharge, and on 6-month morbidity and mortality in a population of moderate and severe adult TBI patients. The investigators also evaluated the role of intracranial hypertension, decreased cerebral perfusion pressure, hypotension and other secondary ischemic insults in determining the appearance of PTCI.

Completed

Looking for future studies?

Notify Me

Key information

Age range

16 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Azienda Ospedaliera Spedali Civili di Brescia

Brescia, 25123, Italy

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • age >15 years old,
  • with moderate or severe head trauma (GCS <14),
  • admitted to ICU. Cases were classified as severe head injury (GCS score < 9), or moderate head injury (GCS score from 9 to 13).

All patients recruited were monitored by means of invasive intracranial pressure (ICP), invasive arterial pressure monitoring, peripheral oxygen saturation, in accordance with published international and local guidelines

Exclusion criteria

  • age <16 years old,
  • mild head trauma,
  • absence of invasive ICP or invasive arterial pressure monitoring,
  • dying patients,
  • absence of brain stem reflexes.

Treatment and study plan

posttraumatic cerebral infarction

Other

the difference between groups refers to the developing of cerebral infarction after traumatic brain injury

Primary outcomes

  1. Oxford Handicap Scale (OHS)

    Time frame: patients will be evaluated at hospital discharge, an expected average of 3 weeks

    The Oxford Handicap Scale evaluates the outcome as follow: 0 no symptoms, 1 minor symptoms, 2 minor handicap, 3 moderate handicap, 4 severe handicap, 5 death.

    Favourable outcome: 0-3; unfavourable outcome: 4-5

  2. Glasgow Outcome Scale (GOS)

    Time frame: the GOS will be performed 6 months after the hospital admission

    The Glasgow Outcome Scale evaluates the outcome as follow: 1 death, 2 vegetative state, 3 severe handicap, 4 moderate handicap, 5 good recovery.

    Favourable outcome: 4-5; unfavourable outcome: 1-3

Secondary outcomes

  1. Hospital and ICU mortality

    Time frame: at the discharge from ICU, an expected average of 3 weeks; and at the discharge from hospital, an expected average of 6 weeks

    This outcome refers to the mortality during ICU stay and hospital stay

  2. Length of ventilation

    Time frame: during ICU stay, an expected average of 3 weeks

    Days of ventilation, how long does it take to weaning from ventilation

  3. Length of ICU and Hospital stay

    Time frame: at the discharge from ICU, an expected average of 3 weeks; and at the discharge from hospital, an expected average of 6 weeks

    How many days the patients whith cerebral infarction and without cerebral infarction have been in ICU, and how many days the patients were in hospital

Sponsors and collaborators

Lead sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia

Other

Collaborators

  • A.O. Ospedale Papa Giovanni XXIII
  • A.O.U. Città della Salute e della Scienza
  • Azienda Ospedaliera San Gerardo di Monza
  • Azienda Ospedaliero, Universitaria Pisana
  • Fondazione IRCCS Policlinico San Matteo di Pavia
  • Fondazione Poliambulanza Istituto Ospedaliero
  • Università degli Studi di Brescia

Registry information

Official study title

Post Traumatic Cerebral Infarction Increases Mortality and Morbidity in Patients With Moderate or Severe Head Trauma. The Multicenter Italian INCEPT (INfarto CErebrale Post-Traumatico) Study

Important dates

Study start
2009
Primary completion
2012
Study completion
2012
First posted
Apr 30, 2015
Registry last updated
Apr 30, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.